OpenAlex
PricingAboutJobs
Log inGet started
Work

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

HTML

Year: 2003
Type: article
Source: Blood
DOI: 10.1182/blood-2003-05-1406
Authors: Rowena D. Faulkner, Charles Craddock, Jennifer L. Byrne, Prem Mahendra, Andrew P. Haynes, Hugh G. Prentice, Michael Potter, Antonio Pagliuca, Aloysius Ho, Stephen Devereux, Grant McQuaker, Ghulam Mufti, John Liu Yin, Nigel H. Russell
Institutions: University Hospitals Birmingham NHS Foundation Trust, Glasgow Royal Infirmary, The Royal Free Hospital, Manchester Royal Infirmary, Nottingham City Hospital, King's College Hospital
Language: English

Topic: Hematopoietic Stem Cell Transplantation
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: reduced-intensity conditioning, allogeneic stem cell transplantation, lymphoproliferative disorders, graft-versus-host disease, donor engraftment, transplantation-related mortality, relapse risk, mantle cell lymphoma, high-grade non-Hodgkin lymphoma, event-free survival, alemtuzumab
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2132589242
FWCI: 9.382
Cites: 28
Cited by: 169
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms